Sartorius Stedim Shares Bounce to €168.10, Crossing a Key Technical Threshold
The French bioproduction equipment specialist continues its recovery mid-morning. Sartorius Stedim Biotech shares are up 2.63% at €168.10, moving above its 50-day moving average. The movement extends the rebound that began last week, in an SBF 120 that is up 0.40%.
A Rebound that Places the Stock Above Its 50-Day Moving Average
Sartorius Stedim Biotech stock is among the top gainers in the SBF 120 session. The stock crosses the 50-day moving average (€167.12) and is now 4.05% above its 20-day moving average at €161.55. The RSI at 50 indicates a return to a balance zone, following a technical oversold phase observed at the end of April, when the price had fallen below the lower Bollinger band at €153.
However, the dynamics remain fragile in the longer term. The 200-day average, at €185.22, still overshadows the current price by 9.24%, and the one-year performance remains negative at -15.95%. The next identified resistance is at €188.70, which is about 12% above the current price. Over the week, the rebound has reached 4.54%.
Quarterly Results and Current Stock Performance
As a reminder, Sartorius Stedim Biotech published its first quarter 2026 results on April 23, reporting revenue of €762 million, up 7.9% at constant exchange rates, but with a slight decline in current EBITDA margin to 30.7%. The subsequent market reaction (nearly a 5% drop that day) had driven the stock down to €153 at the end of April. The current session brings the stock close to its graphical resistance, which will be the next technical level to watch.
